Navigation Links
TLR9 in Medical News

JCI online early table of contents: Jan. 12, 2009

...provided new insight into how drugs that stimulate tlr9 might be beneficial, by showing that they inhibit ...ore have immense clinical potential. In the study, tlr9 was found to be highly expressed by a defined popu...D known as 1-alpha,25VitD3. In vitro, induction of tlr9 was mainly regulated by 1-alpha,25VitD3, and human...

JCI online early table of contents: April 8, 2008

... VIROLOGY A pox on TLR9: the immune molecule tlr9 is crucial to prevent lethal poxvirus infection in... Nordic GmbH, Germany, have identified the protein tlr9 as central to immune defense against infection with some poxviruses in mice. In the study, tlr9 was shown to be essential for mice to mount protec...

Dynavax to Present at CIBC World Markets and Acumen BioFin Rodman and Renshaw Healthcare Conferences

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

Dynavax Announces Third Quarter 2007 Financial Results and Updates 2007 Financial Outlook

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

Dynavax and Merck & Co., Inc. Announce Partnership to Develop HEPLISAV(TM), an Investigational Hepatitis B Vaccine Currently in Phase 3

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

New Round of Lupus Research Institute Awards Brings Promise of More Breakthroughs

... B cell depletion therapy in mice Gregory Barton, PhD University of California, Berkeley The role of ubiquitin-mediated downregulation of TLR7 and tlr9 in lupus Loren Erickson, PhD University of Virginia The Role of Nba2 in Plasma Cell Differentiation Nir Hacohen, PhD Massachusetts General Hosp...

Dynavax to Present at Bear Stearns 20th Annual Healthcare Conference

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

Hope For Patients With Inflammatory Bowel Disease

...o two different groups of mice that appeared similar but were from different genetic strains. Reactions were different in the two strains of mice. The tlr9 activators inhibited the severity of experimental colitis but had no effect on the other group of mice. To understand why the mice reacted differen...
TLR9 in Medical Technology

Idera Pharmaceuticals Announces Presentations of Preclinical Data on New Potential Oncology Applications of its TLR9 Agonists at AACR

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Apr 18, 2007 - Idera Pharmaceuticals, Inc. (AMEX: IDP) today announced two presentations of data for two new potential applications in oncology of its novel agonists of Toll-like receptor 9 (TLR9) at the Annual Meeting of the American Association for Cancer Resear...

Dynavax Presents New Analysis of TOLAMBA(TM) Data at ACAAI Meeting

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

Coley Pharmaceutical Group and Pfizer Nominate Additional Anti-Cancer Compound for Clinical Development

...ator in the area of cancer, has nominated a second tlr9 agonist compound discovered by Coley for future cl... programs for PF-3512676, Coley's lead therapeutic tlr9 agonist drug candidate, for the treatment of cance... and develop a variety of pharmacologically unique tlr9 agonist compounds demonstrates our dexterity in dr...

Coley Pharmaceutical Group Receives $3.0 Million Milestone Payment from GlaxoSmithKline

...disease-free survival. The $3 million development milestone was triggered by the initiation of this Phase III trial. VaxImmune is Coley's proprietary tlr9 agonist designed to induce both an enhanced antibody response and a potent killer T cell immune response when used in conjunction with vaccines in ord...

Dynavax Begins TOLAMBA(TM) Environmental Exposure Chamber Study

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

Dynavax's HEPLISAV(TM) Hepatitis B Vaccine Maintains Full Immunogenicity at 50 Weeks in Phase 3 Trial

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...

MedImmune Highlights Advances in Inflammatory Disease Pipeline With Series of Data Presentations

...ntribute to the pathology of a range of disorders such as joint inflammation and sepsis." Data presented at AAI include: -- "Regulation of tlr9 dependent DNA Immune complex mediated cell activation by High Mobility Group Box Protein 1 (HMGB1) and Receptor for Advanced Glycation...
TLR9 in Biological News

Scripps research scientists solve structure of a critical innate immune system protein

...saccharide, a chemical component of the cell walls of certain bacteria like Neisseria meningitides--one of the leading causes of bacterial meningitis. tlr9 recognizes bacterial DNA that contains distinguishing CpG dinucleotides motifs . TLR3 in Detail Likewise, TLR3 recognizes double-stranded RNA, w...
TLR9 in Biological Technology

Dynavax Issued Landmark Patent Covering Second-Generation TLR9 Agonists

BERKELEY, Calif., Aug. 16 /PRNewswire-FirstCall/ -- Dynavax Technologies Corporation (Nasdaq: DVAX ) today announced that the U.S. Patent Office has issued the company a broad composition of matter patent covering the company's proprietary second-generation TLR9 agonists. The claims cover a ...

Dynavax Reports Progress in Lupus Program With Inhibitor of TLR7 and TLR9

Animal Model Shows Disease Progression Can Be Prevented BERKELEY, Calif., Nov. 26 /PRNewswire-FirstCall/ -- In a paper appearing online in the December issue of The European Journal of Immunology (Vol. 37, Issue 12), Dynavax scientists report the results of studies made possible under ...

Dynavax to Present at UBS 2007 Global Life Sciences Conference

...es Corporation discovers, develops, and intends to commercialize innovative tlr9 agonist-based products to treat and prevent infectious diseases, allergies,... approaches that alter immune system responses in highly specific ways. Our tlr9 agonists are based on immunostimulatory sequences, or ISS, which are short ...
Other Tags
(Date:8/21/2014)... August 21, 2014 The City of ... for entertainment and programming for its inaugural “Re:Imagine Garden ... October 12, 2014, from 11 a.m. to 4 p.m., ... all cars and the downtown will be filled with ... by Community Arts Resources (CARS), for all to enjoy. ...
(Date:8/21/2014)... News) -- Not only is eating better and exercising healthy ... health-care dollars a year, a new study finds. The ... sciences at Wake Forest Baptist Medical Center in Winston-Salem, N.C., ... diabetes patients. Participants ranged in age from ... intensive "lifestyle change program" focused on diet and exercise, or ...
(Date:8/21/2014)... THURSDAY, Aug. 21, 2014 (HealthDay News) -- Among seniors, ... suggests. The study involved more than 2,500 people, aged ... the study and again two, six and eight years later. ... in the person,s risk of death during the study period, ... and effect, researchers led by Sharon Christ of Purdue University ...
(Date:8/21/2014)... The W. Montague Cobb/ NMA ... national voice in the elimination of health disparities, ... the 112th National Medical Association’s (NMA) Annual Convention ... John Ruffin, Ph.D, former Director of the National ... life-long career and innovations have had a significant ...
(Date:8/21/2014)... Rockville, MD (PRWEB) August 21, 2014 ... Pediatrics reported a 63% increase in disability associated with ... along with a more than 15% increase in disability ... of early intervention for rising numbers of children who ... Speech-Language-Hearing Association (ASHA). , On a broader ...
Breaking Medicine News(10 mins):Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 2Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 3Health News:"Re:Imagine Garden Grove - A Downtown Open Streets Event" 4Health News:Getting Healthier a Big Money-Saver for People With Diabetes 2Health News:Failing Vision Tied to Shorter Lifespans for Seniors 2Health News:W. Montague Cobb/NMA Health Institute Honors Three Outstanding Leaders in Health Disparities 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 2Health News:New Pediatrics Study Reveals Dramatic Increase in Speech Problems in Children Over Past Decade 3
(Date:8/21/2014)... LAWRENCE A study recently published in the journal ... Kansas shows a new role for the protein adenomatous ... second-leading cause of cancer-related deaths in the U.S. , ... of Molecular Biosciences and co-leader of the Cancer Biology ... better part of her career trying to understand the ...
(Date:8/21/2014)... North Carolina State University have developed a novel and ... has applications for creating new materials as well as ... new technique allows us to model much larger and ... more quickly," says Nan Li, lead author of a ... NC State,s Department of Materials Science and Engineering. "This ...
(Date:8/20/2014)... LAKE CITY Researchers at Huntsman Cancer Institute (HCI) at ... forms of the gene that encodes BCR-ABL, the unregulated ... According to the American Cancer Society, nearly 6,000 new ... Drugs already in use, called tyrosine kinase inhibitors (TKIs), ... They do not cure CML but control it in ...
Breaking Biology News(10 mins):Research offers insight into cellular biology of colorectal cancer 2Research offers insight into cellular biology of colorectal cancer 3Researchers develop models to study polyelectrolytes, including DNA and RNA 2Blueprint for next generation of chronic myeloid leukemia treatment 2
Other Contents